Chest
Volume 139, Issue 6, June 2011, Pages 1263-1264
EditorialsPredicting Survival in Pulmonary Arterial Hypertension: Time to Combine Markers
References (10)
- et al.
Integration of clinical and hemodynamic parameters in the prediction of long-term survival in patients with pulmonary arterial hypertension
Chest
(2011) - et al.
Updated evidence-based treatment algorithm in pulmonary arterial hypertension
J Am Coll Cardiol
(2009) - et al.
Treatment of pulmonary arterial hypertension
N Engl J Med
(2004) - et al.
Trends in pulmonary arterial hypertension
Eur Respir Rev
(2009) - et al.
Survival in patients with primary pulmonary hypertension. Results from a national prospective registry
Ann Intern Med
(1991)
There are more references available in the full text version of this article.
Cited by (6)
Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension
2017, European Respiratory JournalGoal-oriented treatment of pulmonary arterial hypertension
2014, Current Opinion in Pulmonary MedicineREVEAL: A contemporary US pulmonary arterial hypertension registry
2012, European Respiratory ReviewA decade of achievement in pulmonary hypertension
2011, European Respiratory Review
Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts of interest: Dr Humbert has received consultancy and advisory board fees from Actelion and Novartis, and has received lecture fees from Actelion, BayerSchering, GlaxoSmithKline, Pfizer Inc, and United Therapeutics. Drs Montani and Souza have reported that no potential conflicts of interest exit with any companies/organizations whose products or services may be discussed in this article.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).
Copyright © 2011 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.